Pyrimidine, 5-bromo-4-methyl- (7CI,8CI,9CI) Chemical Properties

Melting point:

215℃

Boiling point:

221.3±20.0℃ (760 Torr)

Density 

1.596±0.06 g/cm3 (20 ºC 760 Torr)

Flash point:

87.7±21.8℃

storage temp. 

2-8°C

pka

0.50±0.16(Predicted)

Appearance

Colorless to light yellow Liquid

InChI

InChI=1S/C5H5BrN2/c1-4-5(6)2-7-3-8-4/h2-3H,1H3

InChIKey

ALRPHTZYJPXPGN-UHFFFAOYSA-N

SMILES

C1=NC=C(Br)C(C)=N1

Safety Information

Hazard Codes 

Xn

Risk Statements 

22-37/38-41

Safety Statements 

26-39

HazardClass 

IRRITANT

HS Code 

2933599590

Pyrimidine, 5-bromo-4-methyl- (7CI,8CI,9CI) Usage And Synthesis

Synthesis

An ether solution of methyl lithium (109 mmol, 1.09 M, 100 mL) was added dropwise to an ether (100 mL) solution of 5-bromopyrimidine (17.3 g, 109 mmol) at room temperature. The resulting reaction mixture was stirred at room temperature for 1 hour. Upon completion of the reaction, water (1.96 mL, 109 mmol) and a solution of tetrahydrofuran (150 mL) of 2,3-dichloro-5,6-dicyano-p-benzoquinone (24.7 g, 109 mmol) were added to the reaction mixture, and stirring was continued for 16 hours at room temperature. Upon completion of the reaction, water and ethyl acetate were added for extraction and the organic layer was separated. The organic layer was washed with 1 M aqueous sodium hydroxide, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexane/ethyl acetate=1/1) to afford the target product 5-bromo-4-methylpyrimidine (2.9 g, 15% yield). Product properties: yellow oil. 1H-NMR (CDCl3) δ: 2.65 (s, 3H), 8.72 (s, 1H), 8.98 (s, 1H).

References

[1] Patent: WO2009/57827, 2009, A1. Location in patent: Page/Page column 167

Pyrimidine, 5-bromo-4-methyl- (7CI,8CI,9CI)(1439-09-4)Related Product Information

• 5-Bromo-2,4-dichloro-6-methylpyrimidine
• 2-AMINO-5-BROMO-4-HYDROXY-6-METHYLPYRIMIDINE
• 5-Bromo-2-(methylthio)pyrimidine-4-carboxylic acid
• 4-AMINO-5-BROMO-6-METHYLPYRIMIDINE
• 2-Amino-5-bromo-4,6-dimethylpyrimidine
• 5-Bromo-2-methyl-4-pyrimidinecarboxylic acid
• 2-AMINO-5-BROMO-4-HYDROXY-6-PHENYLPYRIMIDINE
• 2-Amino-4-methyl-5-bromopyrimidine
• 5-Bromo-4-phenylpyrimidine
• 5-BROMO-4-HYDRAZINO-6-METHYLPYRIMIDINE
• 2-PYRIMIDINAMINE, 5-BROMO-4-CHLORO-6-METHYL-
• 2-(5-BROMO-2-CHLOROPYRIMIDIN-4-YL)-2-(1-METHYL-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-2-YLIDEN)ACETONITRILE
• 2-(1H-BENZO[D]IMIDAZOL-2-YL)-2-(5-BROMO-2-CHLORO-6-METHYLPYRIMIDIN-4-YL)ACETONITRILE
• 5-BROMO-4-HYDRAZINO-2,6-DIPHENYLPYRIMIDINE
• 2-AMINO-4-METHYL-5-BROMO-6-TRIFLUOROPYRIMIDINE
• 4,5-DIBROMO-2,6-DIPHENYLPYRIMIDINE
• SULFABROMOMETHAZINE (PHENYL-13C6)
• 2-(5-BROMO-2-CHLORO-6-METHYLPYRIMIDIN-4-YL)-2-(1-METHYL-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-2-YLIDEN)ACETONITRILE